Stocks · News reference
Evercore ISI Group Initiates Coverage On Electra Therapeutics with Outperform Rating, Announces Price Target of $36
Evercore ISI Group initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Outperform rating and announces Price Target of $36.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
TD Cowen Initiates Coverage On Electra Therapeutics with Buy Rating
TD Cowen analyst Tyler Van Buren initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating.
This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).
Cantor Fitzgerald Initiates Coverage On Electra Therapeutics with Overweight Rating
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating.
8-K filing — Electra Therapeutics, Inc. (ETRA)
Filed: 2026-09-21 AccNo: 0001193125-26-396646 Size: 186 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Electra Therapeutics Opens For Trade At $15/Share; IPO Priced At $15.00/Share On 23.33M Shares